Euroapi: agreement to acquire BianoGMP
(CercleFinance.com) - Euroapi announces that it has signed an agreement to acquire 100% of the shares of BianoGMP, a Contract and Development Manufacturing Organization (CDMO) company with recognised expertise in oligonucleotides.
The transaction costs about E10m, including an upfront payment, a deferred amount and investments to increase BianoGMP's capacity to carry out larger-scale, more complex projects.
The transaction will reinforce Euroapi's position in the fast-growing oligonucleotide market (+12 to +14% p.a.). Completion, subject to the usual conditions, is scheduled for Q4 2023.
Copyright (c) 2023 CercleFinance.com. All rights reserved.